| PATENT REGISTER | |||||||||
| Status | Lapsed | Patent No. | 2889033 | ||||||
|---|---|---|---|---|---|---|---|---|---|
| Application No. | 15151165.6 | Date of Filing | 19/11/2009 | ||||||
| Date Grant Published | 21/03/2018 | Application Published | 01/07/2015 | ||||||
| Title of Invention | Treatment of negative symptoms of schizophrenia with (R)-7-chloro-N-(quinuclidin-3-yl)benzo[b]thiophene-2-carboxamide and pharmaceutically acceptable salts thereof | ||||||||
| Priority |
|
||||||||
| Inventors |
Koenig, Gerhard Chesworth, Richard Shapiro, Gideon |
||||||||
| Current Proprietor |
Forum Pharmaceuticals Inc. 225 Second Avenue Waltham, MA 02451 UNITED STATES OF AMERICA |
||||||||
| Address for service |
RWS TRANSLATIONS 2, rue Sainte Victoire 78000 Versailles FRANCE |
||||||||
| Renewal Fees |
|
||||||||
| Earlier Application No. 09756921.4 | Lapsed | ||||||||
| Earlier Application No. 12185913.6 | Lapsed | ||||||||
| Publication Language | English | ||||||||
| Translation Received Date | |||||||||
| 22/03/2018 | Divisional Application number: 18152484.4 Date of receipt: 19/01/2018 | ||||||||
| 19/06/2018 | Address for Service recorded as RWS TRANSLATIONS, Europa House, Chiltern Park, Chiltern Hill, Chalfont St Peter, Bucks SL9 9FG, United Kingdom received on 18/06/2018. | ||||||||
| 14/10/2020 | Change of Address for Service from RWS TRANSLATIONS, Europa House, Chiltern Park, Chiltern Hill, Chalfont St Peter, Bucks SL9 9FG, United Kingdom to RWS TRANSLATIONS, 2, rue Sainte Victoire, 78000 Versailles, France recorded on 08/10/2020 | ||||||||
| 30/07/2021 | Patent lapsed due to non-payment of Patent Renewal Fee in respect of year 12. | ||||||||
